Tag Archives: INSERM

Heavy Drinking: an Under-Appreciated Dementia Risk Factor? (BBC News / Lancet Public Health)

Posted on February 21, 2018 by Dementia and Elderly Care News

Summary Research based in France has discovered an association between alcohol use disorders and dementia risk, particularly regarding the risk of developing early-onset dementia (i.e. with onset at an age less than 65 years). Full Text Link Reference Alcohol and … Continue reading →

Posted in BBC News, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, International, Mental Health, Quick Insights, Statistics, Universal Interest | Tagged Alcohol, Alcohol Abuse, Alcohol and Dementia, Alcohol Consumption, Alcohol Dependence, Alcohol Misuse, Alcohol Services, Alcohol Use Disorders (AUDs), Alcohol Use Disorders and Cognitive Impairment Risk, Alcohol-Related Dementia, Alcohol-Related Harm, Alcoholic Dementia, BBC Health News, Behavioural Risk Factors, Binge Drinking, Bordeaux University Hospital, Campbell Family Mental Health Research Institute (Toronto), Canada, Cardiovascular Risk Factors (CVRF), Centre for Addiction and Mental Health (Toronto), Centre INSERM U1219-Bordeaux Population Health, Dalla Lana School of Public Health: University of Toronto, Dementia Risk Factors, Department of Psychiatry: University of Toronto, Early-Onset Dementia, Epidemiology, Epidemiology and Statistics, France, French National Hospital Discharge Database (Programme de Médicalisation des Systèmes d'Information), Germany, Harmful Alcohol Use, Infection Antimicrobials Modeling and Evolution: INSERM–Université Paris Diderot, INSERM, INSERM–Université Paris Diderot, Institute for Clinical Psychology and Psychotherapy: Technical University Dresden, Institute for Mental Health Policy Research (Toronto), Institute of Medical Science: University of Toronto, ISPED-Bordeaux School of Public Health, Lancet Public Health, Lifestyle Risk Factors, Medical Information Service (Bordeaux), Modifiable Risk Factors, Overlapping Risk Factors, Psychosocial and Lifestyle-Related Risk Factors, Public Health, Public Health Department (Bordeaux), Public Health Policy, Public Health Policy Against Alcohol-Related Harms, QalyDays Study Group, Risk Factors, Sorbonne Paris Cité, Technical University Dresden, Translational Health Economics Network (Paris), University of Bordeaux, University of Toronto, Vascular Cognitive Impairment, Vascular Dementia, Vascular Risk Factors | Leave a comment

Updated Projections for the Dementia Time-Bomb in England and Wales to 2040 (BMJ)

Posted on July 10, 2017 by Dementia and Elderly Care News

Summary A recent study by researchers University College London (UCL) and the University of Liverpool attempting to assess the future societal burden of dementia (sometimes termed the “Dementia Timebomb”) predicts the number of people living with dementia in England and Wales could … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, National, Quick Insights, Statistics, UK, Universal Interest, Wales | Tagged BMJ, BMJ Publishing Group Ltd, British Medical Journal (BMJ), Burden of Dementia, Burden of Dementia (Statistics), Centre for Dementia Prevention: University of Edinburgh, Centre for Research in Epidemiology and Public Health: Hôpital Paul Brousse, Clinicum, Dementia Incidence Projections: England and Wales to 2040, Dementia Prevalence, Dementia Time-Bomb, Department of Epidemiology and Public Health (University College London), Department of Epidemiology and Public Health: University College, Department of Prevention and Medical Education: Medical University of Gdansk, Department of Public Health and Policy: University of Liverpool, English Longitudinal Study of Ageing (ELSA), Epidemiology, Epidemiology and Statistics, Faculty of Medicine: University of Helsinki, Finland, France, Hôpital Paul Brousse, IMPACT-BAM (IMPACT-Better Ageing Model), IMPACT-Better Ageing Model (IMPACT-BAM), INSERM, Medical University of Gdansk, Poland, Prevalence of Dementia, University College London, University of Edinburgh, University of Helsinki, University of Liverpool, Wider Societal Burden | Leave a comment

Physical Activity in Midlife May Not Reduce Risk of Developing Dementia: No Harm in Trying (BMJ)

Posted on June 27, 2017 by Dementia and Elderly Care News

Summary The general consensus in the literature has tended to suggest that mid-life physical activity is typically beneficial, in part as a lifestyle choice which is likely to contribute to a reduced risk of developing cognitive decline and / or … Continue reading →

Posted in For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Non-Pharmacological Treatments, Quick Insights, Statistics, UK, Universal Interest | Tagged Active Lifestyle, Ageing Population, Association Between Physical Activity and Cognitive Function and / or Dementia, BMJ, British Medical Journal (BMJ), British Medical Journal Publishing Group Limited: Data Release (HSCIC), Centre for Research in Epidemiology and Population Health: Hôpital Paul Brousse, Centre for Research in Epidemiology and Population Health: Université Paris-Saclay, Civil Service Departments in London: Whitehall II Study, Cognitive Decline, Cognitive Decline Studies, Conventional Wisdom, Department of Epidemiology and Public Health (University College London), Environmental and Lifestyle Factors, Epidemiology, Epidemiology and Statistics, France, Hôpital Paul Brousse, Healthy Behaviours, Healthy Lifestyles, Healthy Living, INSERM, INSERM U1219: University of Bordeaux, Lifestyle Factors, Lifestyle Risk Factors, MCI: Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), Moderate Exercise, Modifiable Risk Factors, Myth-Busting, Neuroprotective Lifestyles, Physical Activity and Health Benefits, Physical Activity Before Dementia, Physical Activity for Persons With Dementia, Physical Activity Programmes, Physical Activity Programs for Improvement of Dementia Symptoms, Physical Exercise, Physical Exercise Programmes, Physical Inactivity, Physical Therapy, Possible Myths or Misconceptions: Dementia and Activity (Reverse Causation Fallacy), Preclinical Dementia and Associated Lifestyle Changes, Preclinical Phase of Dementia, Received Wisdom, Sedentary Lifestyles, Trajectories of Physical Activity Before Dementia, Unhealthy Lifestyles, Université Paris-Saclay, University College London, University of Bordeaux, Vascular and Lifestyle Factors, Whitehall II Study, Whitehall Study | Leave a comment

Huntington’s Disease: a Blood Test “Speedometer”? (BBC News / Lancet Neurology)

Posted on June 12, 2017 by Dementia and Elderly Care News

Summary Early research shows promise that a protein biomarker in the blood, called neurofilament light chain (NFL), which is released from damaged brain cells in Huntington’s Disease, may be the basis for a blood test able to predict whether people … Continue reading →

Posted in BBC News, Diagnosis, For Researchers (mostly), In the News, International, Quick Insights, UK, Universal Interest | Tagged BBC Health News, Biomarker Development, Biomarkers, Biomarkers Research Programmes, Blood Tests, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Huntington’s Disease, Blood-Based NfL, Canada, Carver College of Medicine: University of Iowa, Cath Stanley: Chief Executive of Hungtington's Disease Association, Centre for Molecular Medicine and Therapeutics: University of British Columbia, CHDI Foundation, Department of Neurology: Leiden University, Department of Psychiatry and Neurochemistry: Sahlgrenska Academy; University of Gothenburg, Department of Psychiatry: University of Iowa, European Research Council, France, Genetics Department: Pitié-Salpêtrière University Hospital, HTT, HTT Mutation Carriers, Huntington Disease, Huntington's Disease Centre: UCL Institute of Neurology, Huntington’s Disease, INSERM, Institut du Cerveau et de la Moelle épinière (ICM), Institute of Neuroscience and Physiology: Sahlgrenska Academy (University of Gothenburg), Institute of Neuroscience and Physiology: Sahlgrenska Academy at University of Gothenburg, Knut and Alice Wallenberg Foundation, Lancet Neurology, Leiden University, Leonard Wolfson Experimental Neurology Centre: University College London, Medical Research Council (MRC), Mutant Huntingtin (mHTT), National Hospital for Neurology and Neurosurgery, National Institute for Health Research UCL Hospitals Biomedical Research Centre, Netherlands, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurofilament Light Chain (NFL), Neurofilament Light Protein (NF-L), Neurofilament Light Protein in Blood: Potential Biomarker of Huntington's Disease, Neurofilament Light Protein in Blood: Potential Biomarker of Neurodegeneration, Non-Invasive Biomarkers, Pitié-Salpêtrière University Hospital (Paris), Plasma Biomarkers, Plasma Neurofilament Light Chain, Preclinical Biomarkers in Huntington's Disease, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital (Sweden), Serum Neurofilament Light Chain Protein, Sorbonne Universités, Surrogate Biomarkers of Neurodegeneration, Sweden; Clinical Neurochemistry Laboratory: Sahlgrenska University Hospital, Swedish Research Council, Torsten Söderberg Foundation, Transforming Research and Clinical Knowledge in Huntington's Disease (TRACK-HD), UCL Institute of Neurology, University College London (UCL), University of British Columbia, University of Gothenburg, University of Iowa, UPMC University Paris 06: INSERM | Leave a comment

Urine Test for Creutzfeldt-Jakob Disease (CJD)? (BBC News / MRC / JAMA Neurology / NEJM)

Posted on October 4, 2016 by Dementia and Elderly Care News

Summary It may one day be possible to use a non-invasive diagnostic urine test to discover whether or not patients have sporadic Creutzfeldt-Jakob Disease (sCJD). Full Text Link Reference A urine test for Creutzfeldt-Jakob Disease may be possible. London: Medical … Continue reading →

Use of Benzodiazepines and Increased Risk of Alzheimer’s Disease (BBC News / BMJ)

Posted on September 12, 2014 by Dementia and Elderly Care News

Summary Long-term use of benzodiazepines, often prescribed for anxiety and sleep problems, appears to be linked to an increased risk of developing Alzheimer’s Disease. A French-Canadian team of researchers have found a cumulative dose-effect association between exposure to benzodiazepines (over … Continue reading →

Posted in Acute Hospitals, BBC News, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Mental Health, NHS Digital (Previously NHS Choices), Pharmacological Treatments, Quick Insights, Statistics, Universal Interest | Tagged Anxiety, Behind the Headlines, Benzodiazepine Use and Risk of Alzheimer's Disease, Benzodiazepines, BMJ, British Medical Journal (BMJ), Canada Faculty of Pharmacy: University of Montreal, Dose-Response Effect, Epidemiology, French Institute of Public Health Research (IRESP), French Ministry of Health (Direction Générale de la Santé), French National Institute of Health and Medical Research (INSERM), Funding Agency for Health Research of Quebec (Fonds de la Recherche en Santé du Québec) (FRSQ), INSERM, Inserm Research Center for Epidemiology and Biostatistics: Bordeaux, Insomnia, Institute of Health and Medical Research (Inserm), IRESP (Institut de Recherche en Santé Publique), Pharmacoepidemiology, Prescription Sleeping Pills, Quebec Health Insurance Program Database (RAMQ), Research Center of the University of Montreal Hospital Center (CRCHUM), Risk Factors, Risk Factors for Alzheimer's Diseease, Sedatives, Sleeping Pills, Sleeping Problems, Université de Bordeaux, University of Bordeaux: College of Health Sciences, University of Montreal, University of Montreal Hospital Center | Leave a comment

Alzheimer’s Disease Genetics Research: Two New Susceptibility Genes (PloS One)

Posted on July 10, 2014 by Dementia and Elderly Care News

Summary An international collaboration of geneticists investigating susceptibility genes for Alzheimer’s Disease has identified two additional genes (chromosome 8 TP53INP1 and chromosome 14 IGHV1-67). These two genetic susceptibility loci appear to be involved in energy metabolism, protein degradation and the … Continue reading →

Posted in BBC News, For Doctors (mostly), For Researchers (mostly), In the News, International, Mental Health, NHS Digital (Previously NHS Choices), Quick Insights, UK | Tagged Alzheimer's Disease Susceptibility Genes, BBC Health News, Behind the Headlines, Boston University School of Medicine, Boston University School of Public Health, Brigham Young University, Cardiff University, Case Western Reserve University, Centre de Mémoire de Ressources et de Recherche de Bordeaux, Centre for Neuropsychiatric Genetics & Genomics: Cardiff University, Centre Hospitalier Régional Universitaire de Lille, Chromosome 14 IGHV1-67, Chromosome 8 TP53INP1, Collaborative Projects, Collaborative Working, Energy Metabolism, Erasmus MC University Medical Center, Functional Genomics Center Zurich, Gene-Wide Analytical Approaches, Genes Linked to Schizophrenia, Genetic Profiling, Genetic Research, Genetic Susceptibility Loci, Genetic Triggers, Genetic Variants, Genetics of Alzheimer's Disease, Genetics of Schizophrenia, Genome-Wide Association Dataset, Genome-Wide Association Studies (GWAS), Hospital Universitari Vall d'Hebron - Institut de Recerca, Immune System, Innovation in Genetics, INSERM, Institut Pasteur de Lille, International Genomics of Alzheimer's Project Consortium, Karolinska Institutet, McGill University and Génome Québec Innovation Centre, Medical University Graz, MRC Centre for Neuropsychiatric Genetics & Genomics, Nature, Nature Publishing Group, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Novel Susceptibility Loci (Alzheimer's Disease), Protein Degradation, Research and Innovation, Research Consortia, Schizophrenia, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Single Nucleotide Polymorphisms (SNPs), Université Lille 2, University of Bonn, University of Miami, University of Pennsylvania, University of Pennsylvania Perelman School of Medicine, University of Texas Health Sciences Center at Houston, University of Washington, University of Zurich, US National Institute of Mental Health, Vanderbilt Center for Human Genetics Research, Vanderbilt University, Victor Segalen University | Leave a comment

Tag Archives: INSERM

Physical Activity in Midlife May Not Reduce Risk of Developing Dementia: No Harm in Trying (BMJ)

Huntington’s Disease: a Blood Test “Speedometer”? (BBC News / Lancet Neurology)

Use of Benzodiazepines and Increased Risk of Alzheimer’s Disease (BBC News / BMJ)

Alzheimer’s Disease Genetics Research: Two New Susceptibility Genes (PloS One)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites